UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target

Science (American Association for the Advancement of Science), 2009-10, Vol.326 (5950), p.285-289

2009

Volltextzugriff (PDF)

Safety and adherence to intermittent pre-exposure prophylaxis (PrEP) for HIV-1 in African men who have sex with men and female sex workers

PloS one, 2012-04, Vol.7 (4), p.e33103

2012

Volltextzugriff (PDF)

Safety, adherence and acceptability of intermittent tenofovir/emtricitabine as HIV pre-exposure prophylaxis (PrEP) among HIV-uninfected Ugandan volunteers living in HIV-serodiscordant relationships: a randomized, clinical trial

PloS one, 2013-09, Vol.8 (9), p.e74314-e74314

2013

Volltextzugriff (PDF)

Safety and Immunogenicity of a Replication-Incompetent Adenovirus Type 5 HIV-1 Clade B gag/pol/nef Vaccine in Healthy Adults

Clinical infectious diseases, 2008-06, Vol.46 (11), p.1769-1781

2008

Volltextzugriff (PDF)

Immunogenicity of BNT162b2 COVID-19 vaccine in New Zealand adults

Vaccine, 2022-08, Vol.40 (34), p.5050-5059

2022

Volltextzugriff (PDF)

Development and deployment of COVID-19 vaccines for those most vulnerable

Science translational medicine, 2021-02, Vol.13 (579)

2021

Volltextzugriff (PDF)

Safety, pharmacokinetics and antiviral activity of PGT121, a broadly neutralizing monoclonal antibody against HIV-1: a randomized, placebo-controlled, phase 1 clinical trial

Nature medicine, 2021-10, Vol.27 (10), p.1718-1724

2021

Volltextzugriff (PDF)

Adeno-associated virus vectored immunoprophylaxis to prevent HIV in healthy adults: a phase 1 randomised controlled trial

The lancet HIV, 2019-04, Vol.6 (4), p.e230-e239

2019

Volltextzugriff (PDF)

Robust immunogenicity of a third BNT162b2 vaccination against SARS-CoV-2 Omicron variant in a naïve New Zealand cohort

Vaccine, 2023-08, Vol.41 (38), p.5535-5544

2023

Volltextzugriff (PDF)

Understanding Adherence to Daily and Intermittent Regimens of Oral HIV Pre-exposure Prophylaxis Among Men Who Have Sex with Men in Kenya

AIDS and behavior, 2015-05, Vol.19 (5), p.794-801

2015

Volltextzugriff (PDF)

Anal sex, vaginal practices, and HIV incidence in female sex workers in urban Kenya: implications for the development of intravaginal HIV prevention methods

AIDS research and human retroviruses, 2011-10, Vol.27 (10), p.1067-1072

2011

Volltextzugriff (PDF)

Selective removal of stratum corneum by microdermabrasion to increase skin permeability

European journal of pharmaceutical sciences, 2009-09, Vol.38 (2), p.95-103

2009

Volltextzugriff (PDF)

Detection of acute HIV infections in an urban HIV counseling and testing population in the United States

Journal of acquired immune deficiency syndromes (1999), 2007-02, Vol.44 (2), p.196-202

2007

Volltextzugriff (PDF)

An evaluation of intravaginal rings as a potential HIV prevention device in urban Kenya: behaviors and attitudes that might influence uptake within a high-risk population

Journal of women's health (Larchmont, N.Y. 2002), 2008-07, Vol.17 (6), p.1025-1034

2008

Volltextzugriff (PDF)

Safety and immunogenicity of adenovirus-vectored near-consensus HIV type 1 clade B gag vaccines in healthy adults

AIDS research and human retroviruses, 2009-01, Vol.25 (1), p.103-114

2009

Volltextzugriff (PDF)

Safety and Adherence to Intermittent Pre-Exposure Prophylaxis

PloS one, 2012-04, Vol.7 (4), p.e33103

2012

Volltextzugriff (PDF)

Health-Care Providers' Perceptions of Intravaginal Rings for HIV Prevention in Nairobi, Kenya

African journal of midwifery and women's health, 2013-07, Vol.7 (3), p.144-150

2013

Volltextzugriff (PDF)

Safety and Immunogenicily of a Replication-Incompetent Adenovirus Type 5 HIV-1 Clade B Gag/pol/nef Vaccine in Healthy Adults

Clinical infectious diseases, 2008-06, Vol.46 (11), p.1769-1781

2008

Volltextzugriff (PDF)

Management of Pelvic Inflammatory Disease by Primary Care Physicians: A Comparison With Centers for Disease Control and Prevention Guidelines

Sexually transmitted diseases, 1996-03, Vol.23 (2), p.157-163

1996

Volltextzugriff (PDF)

Management of pelvic inflammatory disease by primary care physicians

Sexually transmitted diseases, 1996-03, Vol.23 (2), p.157

1996

Volltextzugriff (PDF)

Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)

The Lancet (British edition), 2018-07, Vol.392 (10143), p.232-243

2018

Volltextzugriff (PDF)

Humoral Immunogenicity of mRNA-1345 RSV Vaccine in Older Adults

The Journal of infectious diseases, 2024-06

2024

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(30)

Sprache

Englisch
(30)

Erscheinungsjahr

n.n

Thema

Science & Technology
(24)
Humans
(21)
Life Sciences & Biomedicine
(21)
Adult
(15)
Infectious Diseases
(15)
Male
(15)
Female
(14)
Immunology
(13)
Middle Aged
(13)
Hiv
(11)
Human Immunodeficiency Virus
(11)
Biological And Medical Sciences
(10)
Adolescent
(9)
Medical Sciences
(9)
Microbiology
(9)
Vaccines
(9)
Viral Diseases
(9)
Hiv Infections - Prevention & Control
(8)
Human Viral Diseases
(7)
Virology
(7)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target

Safety and adherence to intermittent pre-exposure prophylaxis (PrEP) for HIV-1 in African men who have sex with men and female sex workers

Human Immunodeficiency Virus Type 1 Elite Neutralizers: Individuals with Broad and Potent Neutralizing Activity Identified by Using a High-Throughput Neutralization Assay together with an Analytical Selection Algorithm

Safety, adherence and acceptability of intermittent tenofovir/emtricitabine as HIV pre-exposure prophylaxis (PrEP) among HIV-uninfected Ugandan volunteers living in HIV-serodiscordant relationships: a randomized, clinical trial

Safety and Immunogenicity of a Replication-Incompetent Adenovirus Type 5 HIV-1 Clade B gag/pol/nef Vaccine in Healthy Adults

Immunogenicity of BNT162b2 COVID-19 vaccine in New Zealand adults

Development and deployment of COVID-19 vaccines for those most vulnerable

Safety, pharmacokinetics and antiviral activity of PGT121, a broadly neutralizing monoclonal antibody against HIV-1: a randomized, placebo-controlled, phase 1 clinical trial

Adeno-associated virus vectored immunoprophylaxis to prevent HIV in healthy adults: a phase 1 randomised controlled trial

Robust immunogenicity of a third BNT162b2 vaccination against SARS-CoV-2 Omicron variant in a naïve New Zealand cohort

Association Between SARS-CoV-2 Viral Load and COVID-19 Vaccination in 4 Phase 3 Trials

Understanding Adherence to Daily and Intermittent Regimens of Oral HIV Pre-exposure Prophylaxis Among Men Who Have Sex with Men in Kenya

Anal sex, vaginal practices, and HIV incidence in female sex workers in urban Kenya: implications for the development of intravaginal HIV prevention methods

Selective removal of stratum corneum by microdermabrasion to increase skin permeability

Detection of acute HIV infections in an urban HIV counseling and testing population in the United States

An evaluation of intravaginal rings as a potential HIV prevention device in urban Kenya: behaviors and attitudes that might influence uptake within a high-risk population

Safety and immunogenicity of adenovirus-vectored near-consensus HIV type 1 clade B gag vaccines in healthy adults

Safety and Adherence to Intermittent Pre-Exposure Prophylaxis

Health-Care Providers' Perceptions of Intravaginal Rings for HIV Prevention in Nairobi, Kenya

Safety and Immunogenicily of a Replication-Incompetent Adenovirus Type 5 HIV-1 Clade B Gag/pol/nef Vaccine in Healthy Adults

Management of Pelvic Inflammatory Disease by Primary Care Physicians: A Comparison With Centers for Disease Control and Prevention Guidelines

Management of pelvic inflammatory disease by primary care physicians

Adeno-Associated Virus Vectored Immunoprophylaxis to Prevent HIV: A Phase 1 Randomized Controlled Trial in Healthy Adults

Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)

Humoral Immunogenicity of mRNA-1345 RSV Vaccine in Older Adults

Suchergebnisse filtern